Swiss Canton St Gallen Launches Large-Scale Cannabis Study
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyTHCCBDHempIndustry Why This Matters This large-scale Swiss study will generate rigorous evidence on…
Study shows branding on cannabis products appeals to youth – News-Medical.Net
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryPediatricsPainAnxiety Why This Matters Clinicians need to understand that aggressive product…
Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainTHCCBDResearchSafetyPolicyAnxiety Why This Matters Clinicians treating chronic pain patients need this data because…
Exilby: Europe’s First Standardized Cannabis Medicine Approved
Exilby marks a milestone as the first standardized cannabis medicine Europe has approved. This pharmaceutical-grade product offers consistent THC dosing unlike unregulated cannabis. Clinicians can now consider Exilby for safer, predictable therapeutic…
Germany Approves First Standardised Cannabis Painkiller as Alternative to Opioids
✦ New CED Clinical Relevance #80 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainPolicyIndustryResearchSafetyTHCCBD Why This Matters This approval provides clinicians with a regulated,…
Governor Ayotte vetoes bipartisan bill to expand cultivation of medicinal marijuana
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyIndustryPainAnxietyMental HealthSafetyResearch Why This Matters Vetoing this cultivation expansion bill delays…
Cannabis branding may appeal to youth despite regulations, study finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryPediatricsMental HealthTHC Why This Matters Clinicians should understand that cannabis…
A large-scale cannabis study is launching in the canton of St. Gallen | blue News
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyMental HealthHempTHCCBD Why This Matters I need to see the full article content to provide clinically…
Pleopharma To Present New Data on Cannabis Withdrawal in Patients With …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyTHCAnxietyDosingNeurology Why This Matters Clinicians treating cannabis use disorder need…
Leafwell Publishes New PTSD Study, Builds on Evidence Supporting Medical Cannabis for …
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchPainSafetyPolicyAnxietyNeurology Clinical Summary # Clinical Summary This study contributes to…
